Tobias Kull (T Kull)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Hematopoietic Stem Cell

Top Venues

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Arne Wehling, Dirk Loeffler, Yang Zhang, Tobias Kull, C Donato, B Szczerba, Germán Camargo Ortega, Minkyoung Lee, A Moor, B Göttgens, N Aceto, Timm Schroeder
Combining single-cell tracking and omics improves blood stem cell fate regulator identification. Blood 140 (13) (2022)
Tobias Kull, Arne Wehling, Martin Etzrodt, Markus Auler, Philip Dettinger, Nicola Aceto, Timm Schroeder
NfκB signaling dynamics and their target genes differ between mouse blood cell types and induce distinct cell behavior. Blood 140 (2) (2022)
Tobias Kull, Timm Schroeder
Analyzing signaling activity and function in hematopoietic cells. The Journal of experimental medicine 218 (7) (2021)
Weijia Wang, Yang Zhang, Philip Dettinger, Andreas Reimann, Tobias Kull, Dirk Loeffler, Markus G Manz, Claudia Lengerke, Timm Schroeder
Cytokine combinations for human blood stem cell expansion induce cell-type- and cytokine-specific signaling dynamics. Blood 138 (10) (2021)
Nouraiz Ahmed, Martin Etzrodt, Philip Dettinger, Tobias Kull, Dirk Loeffler, Philipp S Hoppe, James S Chavez, Yang Zhang, Germán Camargo Ortega, Oliver Hilsenbeck, Hideaki Nakajima, Eric M Pietras, Timm Schroeder
Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulation. The Journal of experimental medicine 219 (1) (2021)
Dirk Loeffler, Florin Schneiter, Weijia Wang, Arne Wehling, Tobias Kull, Claudia Lengerke, Markus G Manz, Timm Schroeder
Asymmetric organelle inheritance predicts human blood stem cell fate. Blood (2021)